Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Teva Continues To Be Oversold And Undervalued (NYSE:TEVA) | Seeking Alpha
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 | Reuters
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
Form 6-K
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Pharmaceutical revenue 2006-2021 | Statista
Teva Pharmaceutical Industries (NYSE:TEVA) Has No Shortage Of Debt | Nasdaq
Teva climbs on report it is mulling 10,000 job cuts | Financial Times
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
The Possible Reason why Teva (NYSE:TEVA) is Still Trading Below Intrinsic Value - Simply Wall St News
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
Deckers Outdoor Corporation 2021 Annual Report
Teva Announces Sale of Remaining Assets in Specialty Global Women's Health Portfolio for $1.38 Billion – Sawaya Partners., LLC
Teva Pharmaceutical's (NYSE: TEVA) Ice-Cube Business Model | Seeking Alpha
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals on Twitter: "Yesterday we shared Teva's business results for Q4 and full year 2021. Learn more here: https://t.co/ZWekP2kzJy #QuarterlyResults #Earnings $Teva Forward-looking statements are subject to the cautionary note included
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire